Biotechnology

Techseriesinsight > Blog > News > Biotechnology

August 14, 2025
PRNewswire
Biotechnology, Healthcare, News

Infectious Disease Therapies Market Projected to Reach $101 Billion by End of 2030

According to the latest study from BCC Research, “Global Markets for Infectious Disease Treatments” is expected to grow from $72.5 billion in 2025 to $101 billion by the end of 2030, at a...

August 12, 2025
Business Wire
Artificial Intelligence, Biotechnology, Healthcare, News

BostonGene Publishes Landmark Study Providing Clinical and Analytical Validation for Its Multimodal RNA and DNA Assay

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced the publication of a pivotal study, “Clinical and analytical validation of a combined RNA and DNA...

August 11, 2025
PRNewswire
Biotechnology, Healthcare, News

New GMP AAV Facility by ProBio to Boost Gene Therapy Manufacturing

ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced the launch of its cGMP Adeno-Associated Virus (AAV) manufacturing services at its...

August 8, 2025
PRNewswire
Biotechnology, Business Broadcast, News

DermRays Celebrates 13 Years of Innovation with Advanced 810nm and 1064nm Diode Laser Hair Removal Technology

As DermRays marks its 13th anniversary, the pioneering beauty tech brand reaffirms its commitment to delivering safe, effective, and inclusive laser hair removal solutions for all skin tones and genders...

August 7, 2025
Business Wire
Biotechnology, News

Options Recognized in Broadcom / VMware’s Global Partner Program, Cementing Position Among Leading Private Cloud Providers Worldwide

Options Technology, the leading provider of infrastructure services to the global capital markets, today announced its continued partner recognition as part of the recently restructured VMware Cloud Service Provider...

August 7, 2025
PRNewswire
Biotechnology, News

Minghui Pharmaceutical Announces USD 131 Million Pre-IPO Financing to Advance Late-Stage Pipeline and Global Expansion

Minghui Pharmaceutical (“Minghui”), a late-stage clinical biopharmaceutical company, today announced the closing of a USD 131 million Pre-IPO financing led by new investors OrbiMed and co-led by Qiming Venture Partners. Further...

August 7, 2025
PRNewswire
Biotechnology, News

German Enterprises Take the Lead in Europe’s SDN Adoption Surge

HTX, a leading global crypto exchange, made a notable appearance at GM Vietnam 2025 – Vietnam Blockchain Week, held from August 1–2, 2025. As a proud sponsor of the Business Networking...

Texas-Life-Science-Forum-2025-to-Unite-Innovators

August 6, 2025
Business Wire
Biotechnology, Healthcare, News

BitNile.com Unveils $NILE Ecosystem on Solana

Rice Alliance for Technology & Entrepreneurship and BioHouston proudly present the 14th Annual Texas Life Science Forum, returning to Houston on November 11th, 2025. As the state’s leading conference...

August 5, 2025
PRNewswire
Biotechnology, News

LungVision Granted Pre‑Market Approval in Singapore

Body Vision Medical, a leader in AI-powered intraoperative imaging, is pleased to announce that its LungVision advanced imaging platform has received Pre-Market Approval from Singapore’s Health Sciences Authority (HSA). This clearance...

August 5, 2025
PRNewswire
Biotechnology, News

Oncolytics Announces AGM and Q2 2025 Results Release

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced that its upcoming 2025 Annual General Meeting (the “Meeting”) will be held...